JAMA Editors' Summary

Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on

04.18.2023 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 18, 2023, issue. Related Content: Audio Highlights

More episodes from JAMA Editors' Summary